No. 1711Independent rewrite deskUpdated September 13, 2026
ENERGYParkinson's incidence set to double as gene therapy pipeline advancesSep 13EARNINGSDestination XL Posts Its Strongest Comp in Three Years While Traffic Stays NegativeSep 13NVDAJim Cramer's $500 billion Nvidia buyback pitch puts Apple's cash model in the frameSep 13MACROEngland to clarify student loan terms after MPs raise concernsSep 13SOARVolato Group closes Alignment Engine merger, Aligned securityholders to hold 95% of SOAR common stockSep 13MACROReform UK's 72 million pound cryptocurrency donation in focus as party asserts backers expect nothing in returnSep 13MACROMusk calls competitor peer review the right starting point for AI oversightSep 13$BTCBitcoin needs $81,700 to confirm the bull case, CryptoQuant saysSep 12TECHAmodei calls for slower AI capability gains as Musk and Altman back the shiftSep 12MACROOpenAI IPO off the 2026 calendar, Altman saysSep 12ENERGYParkinson's incidence set to double as gene therapy pipeline advancesSep 13EARNINGSDestination XL Posts Its Strongest Comp in Three Years While Traffic Stays NegativeSep 13NVDAJim Cramer's $500 billion Nvidia buyback pitch puts Apple's cash model in the frameSep 13MACROEngland to clarify student loan terms after MPs raise concernsSep 13SOARVolato Group closes Alignment Engine merger, Aligned securityholders to hold 95% of SOAR common stockSep 13MACROReform UK's 72 million pound cryptocurrency donation in focus as party asserts backers expect nothing in returnSep 13MACROMusk calls competitor peer review the right starting point for AI oversightSep 13$BTCBitcoin needs $81,700 to confirm the bull case, CryptoQuant saysSep 12TECHAmodei calls for slower AI capability gains as Musk and Altman back the shiftSep 12MACROOpenAI IPO off the 2026 calendar, Altman saysSep 12
Energy
Parkinson's incidence set to double as gene therapy pipeline advances
Parkinson's disease is growing faster than any other neurological condition worldwide, with incidence projected to double in the coming decades, according to a physician and scientist with more than 20 years specializing in the disease…
By Renata OstrowskiNewsroomSeptember 13, 20262 min read
Across the Markets
No. 1711Latest News
All stories→Latest on the Wire
From the Masthead
A press release isn’t news until someone reads it.
MarketPR sits where the wire meets the page. We don’t republish — we read the primary document, find the number that matters, and write our own summary of what it says.
How the newsroom works→
Wire to Front Page
From the wire to the front page.
01
It Crosses
A company release or regulatory filing is published by the issuer or the regulator and lands in our source feed.
02
We Read It
We read the source document and write an original summary of what it says, in our own words.
03
It Ships
The rewrite publishes to the front page with a link back to the primary source it was written from.